208 related articles for article (PubMed ID: 25691679)
1. Disparities in castration-resistant prostate cancer trials.
Spratt DE; Osborne JR
J Clin Oncol; 2015 Apr; 33(10):1101-3. PubMed ID: 25691679
[No Abstract] [Full Text] [Related]
2. Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.
Halabi S; Dutta S; Tangen CM; Rosenthal M; Petrylak DP; Thompson IM; Chi KN; Araujo JC; Logothetis C; Quinn DI; Fizazi K; Morris MJ; Eisenberger MA; George DJ; De Bono JS; Higano CS; Tannock IF; Small EJ; Kelly WK
J Clin Oncol; 2019 Feb; 37(5):403-410. PubMed ID: 30576268
[TBL] [Abstract][Full Text] [Related]
3. Racial Discrepancies in Overall Survival among Men Treated with
Zhao H; Howard LE; De Hoedt A; Terris MK; Amling CL; Kane CJ; Cooperberg MR; Aronson WJ; Klaassen Z; Polascik TJ; Vidal AC; Freedland SJ
J Urol; 2020 Feb; 203(2):331-337. PubMed ID: 31479407
[TBL] [Abstract][Full Text] [Related]
4. The timing of radium-223 therapy in castration-resistant prostate cancer.
Sartor O
Clin Adv Hematol Oncol; 2015 Sep; 13(9):570-2. PubMed ID: 26452186
[No Abstract] [Full Text] [Related]
5. Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer.
Modi D; Hwang C; Mamdani H; Kim S; Gayar H; Vaishampayan U; Joyrich R; Heath EI
Clin Genitourin Cancer; 2016 Oct; 14(5):373-380.e2. PubMed ID: 27053499
[TBL] [Abstract][Full Text] [Related]
6. Nursing management of patients with castration-resistant prostate cancer undergoing radium-223 dichloride treatment.
Delacruz A; Arauz G; Curley T; Lindo A; Jensen T
Clin J Oncol Nurs; 2015 Apr; 19(2):E31-5. PubMed ID: 25840395
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer - Therapy with radium-223.
Brito AE; Amorim BJ; Martello M; Bernardo WM; Etchebehere E;
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1019-1023. PubMed ID: 29489974
[No Abstract] [Full Text] [Related]
8. Use of radium-223 in men with metastatic castration-resistant prostate cancer.
Parker C
Clin Adv Hematol Oncol; 2015 Nov; 13(11):723-5. PubMed ID: 27058695
[No Abstract] [Full Text] [Related]
9. Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
Shore N; Higano CS; George DJ; Sternberg CN; Saad F; Tombal B; Miller K; Kalinovsky J; Jiao X; Tangirala K; Sartor O
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):680-688. PubMed ID: 32404868
[TBL] [Abstract][Full Text] [Related]
10. Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer.
Li J; Armstrong AJ
Clin Adv Hematol Oncol; 2015 May; 13(5):293-8. PubMed ID: 26352773
[No Abstract] [Full Text] [Related]
11. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
12. Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Docetaxel still the optimal first choice for symptomatic metastatic castration-resistant prostate cancer.
Dreicer R
Clin Adv Hematol Oncol; 2015 May; 13(5):293-5. PubMed ID: 26352772
[No Abstract] [Full Text] [Related]
13. Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California.
Barkin J
Can J Urol; 2016 Jun; 23(3):8306-7. PubMed ID: 27347626
[No Abstract] [Full Text] [Related]
14. Targeted radionuclides for prostate cancer bone metastases.
Ito T; Bilusic M; Chen D
Urol Oncol; 2015 Jan; 33(1):2-6. PubMed ID: 25671235
[No Abstract] [Full Text] [Related]
15. Racial disparities in outcomes of colorectal cancer screening: biology or barriers to optimal care?
Ayanian JZ
J Natl Cancer Inst; 2010 Apr; 102(8):511-3. PubMed ID: 20357246
[No Abstract] [Full Text] [Related]
16. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
Saad F; Carles J; Gillessen S; Heidenreich A; Heinrich D; Gratt J; Lévy J; Miller K; Nilsson S; Petrenciuc O; Tucci M; Wirth M; Federhofer J; O'Sullivan JM;
Lancet Oncol; 2016 Sep; 17(9):1306-16. PubMed ID: 27473888
[TBL] [Abstract][Full Text] [Related]
17. Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.
Morris MJ; Loriot Y; Sweeney CJ; Fizazi K; Ryan CJ; Shevrin DH; Antonarakis ES; Pandit-Taskar N; Deandreis D; Jacene HA; Vesselle H; Petrenciuc O; Lu C; Carrasquillo JA; Higano CS
Eur J Cancer; 2019 Jun; 114():107-116. PubMed ID: 31082669
[TBL] [Abstract][Full Text] [Related]
18. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M; Parker C; Saad F; Miller K; Tombal B; Ng QS; Boegemann M; Matveev V; Piulats JM; Zucca LE; Karyakin O; Kimura G; Matsubara N; Nahas WC; Nolè F; Rosenbaum E; Heidenreich A; Kakehi Y; Zhang A; Krissel H; Teufel M; Shen J; Wagner V; Higano C
Lancet Oncol; 2019 Mar; 20(3):408-419. PubMed ID: 30738780
[TBL] [Abstract][Full Text] [Related]
19. [Targeted radionuclide therapy for castration-resistant prostate cancer].
Nakamura K; Ohga S; Sasaki T; Baba S; Honda H
Nihon Rinsho; 2014 Dec; 72(12):2181-5. PubMed ID: 25518355
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer.
Parente P; Parnis F; Gurney H
Asia Pac J Clin Oncol; 2014 Sep; 10(3):205-15. PubMed ID: 24750803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
